HTL logo

Hamilton Thorne Stock Price

Symbol: TSX:HTLMarket Cap: CA$345.3mCategory: Healthcare

HTL Share Price Performance

HTL Community Fair Values

    Recent HTL News & Updates

    No updates

    Hamilton Thorne Ltd. Key Details

    US$76.3m

    Revenue

    US$37.4m

    Cost of Revenue

    US$38.9m

    Gross Profit

    US$40.9m

    Other Expenses

    -US$2.1m

    Earnings

    Last Reported Earnings
    Sep 30, 2024
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.014
    Gross Margin
    50.92%
    Net Profit Margin
    -2.74%
    Debt/Equity Ratio
    29.9%

    Hamilton Thorne Ltd. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About HTL

    Founded
    n/a
    Employees
    n/a
    CEO
    Ekaterina Torchilin
    WebsiteView website
    www.hamiltonthorne.ltd

    Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, the company manufactures and distributes medical products for reproductive medicine; manufactures bespoke workstations, incubators, and equipment for IVF laboratories; researches, designs, develops, sells, installs, and services in-vitro diagnostic systems; and manufactures ovum pickup needles, catheters, and other devices. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as capital equipment and consumables, software, and other services. It sells its products and services under Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech brand names through a direct sales force in the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 100 countries. Hamilton Thorne Ltd. is headquartered in Beverly, Massachusetts.

    U.S. Market Performance

    • 7 Days: 0.9%
    • 3 Months: 23.0%
    • 1 Year: 14.8%
    • Year to Date: 6.9%
    In the last week, the market has been flat, with a notable exception in the Energy sector dropping 3.3%. More promisingly, the market is up 15% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
    The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
    Continue reading